Global uptake of biosimilars
06:26 EDT 3 Aug 2012 | GaBI online
About 85% of the human world population lives in an emerging economy, where biosimilars are less-regulated or even unregulated. Taking into account the huge cost of originator biologicals, and with the growing affluence and purchasing power in these..
Original Article: Global uptake of biosimilars
More From BioPortfolio on "Global uptake of biosimilars"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
